1. New Biogen data showed no major safety issues for its Alzheimer's drug — Lilly puts its oncology future in Lox’s hands — Sage Therapeutics depression drug fails phase 3 trial — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Merrimack Pharma

Anonymous board for Merrimack Pharma


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    1
    Views:
    2,876
  2. anonymous
    Replies:
    0
    Views:
    1,734
  3. anonymous
    Replies:
    7
    Views:
    3,458
  4. anonymous
    Replies:
    0
    Views:
    1,699
  5. anonymous
    Replies:
    4
    Views:
    3,206
  6. anonymous
    Replies:
    5
    Views:
    2,226
  7. anonymous
    Replies:
    28
    Views:
    7,491
  8. anonymous
    Replies:
    13
    Views:
    3,189
  9. anonymous
    Replies:
    23
    Views:
    8,735
  10. anonymous
    Replies:
    5
    Views:
    2,911

Thread Display Options

Loading...